Axa S.A. Grows Stock Position in The Clorox Company (NYSE:CLX)

Axa S.A. boosted its position in shares of The Clorox Company (NYSE:CLX) by 114.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 91,086 shares of the company’s stock after buying an additional 48,524 shares during the quarter. Axa S.A.’s holdings in Clorox were worth $14,793,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of CLX. California Public Employees Retirement System boosted its stake in shares of Clorox by 1.3% during the 4th quarter. California Public Employees Retirement System now owns 565,810 shares of the company’s stock worth $91,893,000 after purchasing an additional 6,987 shares during the period. Fifth Third Wealth Advisors LLC bought a new stake in Clorox in the fourth quarter worth about $204,000. Apollon Wealth Management LLC boosted its position in shares of Clorox by 119.6% during the fourth quarter. Apollon Wealth Management LLC now owns 3,364 shares of the company’s stock valued at $546,000 after buying an additional 1,832 shares during the period. Miracle Mile Advisors LLC bought a new position in shares of Clorox during the fourth quarter valued at approximately $1,566,000. Finally, Wellington Management Group LLP raised its holdings in shares of Clorox by 18.8% in the fourth quarter. Wellington Management Group LLP now owns 4,074 shares of the company’s stock worth $662,000 after buying an additional 646 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 0.2 %

Shares of NYSE:CLX opened at $138.88 on Monday. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The company has a market capitalization of $17.11 billion, a PE ratio of 37.95, a P/E/G ratio of 2.62 and a beta of 0.60. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The business’s fifty day simple moving average is $144.14 and its 200-day simple moving average is $154.85.

Clorox (NYSE:CLX) last announced its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the firm earned $2.16 earnings per share. As a group, equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.51%. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Analyst Ratings Changes

Several equities analysts have commented on CLX shares. Citigroup cut their price objective on Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a research report on Monday, April 14th. DA Davidson cut their price target on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. UBS Group decreased their price objective on shares of Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a report on Thursday, April 17th. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Finally, Wells Fargo & Company decreased their price target on shares of Clorox from $155.00 to $145.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 16th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $153.83.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.